Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
December 09, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis

aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
November 15, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis

aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis
November 07, 2024 16:01 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update

aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
October 31, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at Upcoming Investor Conferences

aTyr Pharma to present at upcoming investor conferences
October 08, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting

aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting
October 02, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal

aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
August 21, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Participate in September Investor Conferences

aTyr Pharma to Participate in September Investor Conferences
August 13, 2024 16:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update

aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
August 06, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations

aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right